4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000046
Chief Legal Officer sold 2,642 shares at $32.57 ($86,050)
- Chief Legal Officer acquired 7,834 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Burns James William · Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,834 | 35,811 | D | ||
| 2024-03-05 | Sale : show line 2 in the form 10b5-1 | −1,293 | $32.57 | $42,113 | 34,518 | D |
| 2024-03-01 | Exercise or conversion : show line 3 in the form 10b5-1 | +4,000 | 38,518 | D | ||
| 2024-03-05 | Sale : show line 4 in the form 10b5-1 | −1,349 | $32.57 | $43,937 | 37,169 | D |
| Open-market sales · 2,642 sh · avg $32.57 · $86,050 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-01 | Grant or award : show line 5 in the form 10b5-1 Restricted stock units | +17,000 | 17,000 | D |
| 2024-03-01 | Grant or award : show line 6 in the form 10b5-1 Stock options (right to buy) | +60,000 | 60,000 | D |
| 2024-03-01 | Exercise or conversion : show line 7 in the form 10b5-1 Restricted stock units | −3,834 | 3,833 | D |
| 2024-03-01 | Exercise or conversion : show line 8 in the form 10b5-1 Restricted stock units | −4,000 | 8,000 | D |
Loading xslF345X05/wk-form4_1709672898.xml…